The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio

Daniel Gabriel Pons; Mercedes Nadal‐Serrano; Margalida Torrens‐Mas; Jordi Oliver; Pilar Roca

doi:10.1002/jcb.25268

journal article Nov 19, 2015

The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio

Daniel Gabriel Pons

Mercedes Nadal‐Serrano Margalida Torrens‐Mas Jordi Oliver

Pilar Roca

Journal of Cellular Biochemistry Vol. 117 No. 1 pp. 218-229 · Wiley

View at Publisher Save 10.1002/jcb.25268

Abstract

ABSTRACTGenistein (GEN) is a phytoestrogen found in soybeans. GEN exerts its functions through its interaction with the estrogen receptors (ER), ERα and ERβ, and we previously reported that the ERα/ERβ ratio is an important factor to consider in GEN‐treated breast cancer cells. The aim of this study was to investigate the effects of GEN in breast cancer cells with different ERα/ERβ ratio: MCF‐7 (high ratio), T47D (low ratio), and MCF‐7 overexpressing ERβ (MCF7 + ERβ) treated with cisplatin (CDDP), paclitaxel (PTX) or tamoxifen (TAM). Cell viability, ROS production, autophagy, apoptosis, antioxidant enzymes protein levels, and cell cycle were analyzed. GEN treatment provoked an increase in cell viability in MCF‐7 cells and in the antioxidant enzymes protein levels in combination with the cytotoxic agents, decreasing ROS production (CDDP + GEN and TAM+GEN) and autophagy (TAM + GEN) or apoptosis (CDDP + GEN and TAM + GEN). Moreover GEN treatment enhanced the cell cycle S phase entry in CDDP+GEN‐ and TAM + GEN‐treated MCF‐7 cells and, in the case of CDDP + GEN, increased the proportion of cells in the G2/M phase and decreased it in the subG0/G1 phase. Otherwise, in the T47D and MCF7 + ERβ cells the combination of GEN with cytotoxic treatments did not cause significant changes in these parameters, even TAM + GEN‐treated T47D cells showed less cell viability due to an increment in the autophagy. In conclusion, GEN consumption may be counterproductive in those patients receiving anticancer treatment with a high ERα/ERβ ratio diagnosed breast cancer and it could be harmless or even beneficial in those patients with a lower ERα/ERβ ratio breast cancer cells. J. Cell. Biochem. 117: 218–229, 2016. © 2015 Wiley Periodicals, Inc.

Topics

No keywords indexed for this article. Browse by subject →

References

44

[1]

10.1016/s1470-2045(02)00777-5

[2]

10.4161/auto.6083

[3]

10.1016/s0014-5793(02)03691-8

[4]

10.1073/pnas.83.8.2496

[5]

10.1586/era.11.111

[6]

10.1210/en.2006-0563

[7]

10.1210/jc.2003-032065

[8]

Chuang JY "Induction of G0/G1 arrest and apoptosis by 3‐hydroxycinnamic acid in human cervix epithelial carcinoma (HeLa) cells" In Vivo (2005)

[9]

Davis CA "Manganese superoxide dismutase attenuates Cisplatin‐induced renal injury: Importance of superoxide" J Am Soc Nephrol (2001) 10.1681/asn.v12122683

[10]

10.1146/annurev.arplant.55.031903.141729

[11]

10.1002/jps.2600640504

[12]

10.1016/j.bbamcr.2014.10.003

[13]

10.1074/jbc.271.23.13504

[14]

10.1007/s12672-012-0123-9

[15]

Hsieh CY "Estrogenic effects of genistein on the growth of estrogen receptor‐positive human breast cancer (MCF‐7) cells in vitro and in vivo" Cancer Res (1998)

[16]

Jensen EV "The estrogen receptor: A model for molecular medicine" Clin Cancer Res (2003)

[17]

10.1007/pl00000762

[18]

Ju YH "Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen‐dependent human breast cancer (MCF‐7) cells implanted in Athymic mice" Cancer Res (2002)

[19]

10.1242/jcs.01131

[20]

10.1210/endo.138.3.4979

[21]

10.1210/endo.139.10.6216

[22]

10.1146/annurev.nutr.17.1.353

[23]

10.1007/s13238-014-0053-0

[24]

10.1371/journal.pone.0081162

[25]

Contaminants in Human Milk: Weighing the Risks against the Benefits of Breastfeeding

M. Nathaniel Mead

Environmental Health Perspectives 10.1289/ehp.116-a426

[26]

10.1093/jn/131.11.3095s

[27]

10.1093/jn/131.10.3168

[28]

10.1016/j.biocel.2013.07.002

[29]

10.1002/jcb.24192

[30]

10.4161/cbt.11.10.15493

[31]

10.1089/jmf.2009.1359

[32]

Genistein Modulates Proliferation and Mitochondrial Functionality in Breast Cancer Cells Depending on ERalpha/ERbeta Ratio

Daniel Gabriel Pons, Mercedes Nadal‐Serrano, M. Mar Blanquer‐Rossello et al.

Journal of Cellular Biochemistry 10.1002/jcb.24737

[33]

10.1159/000226123

[34]

Rajah TT "Physiological concentrations of genistein and 17beta‐estradiol inhibit MDA‐MB‐231 breast cancer cell growth by increasing BAX/BCL‐2 and reducing pERK1/2" Anticancer Res (2012)

[35]

10.1038/onc.2012.335

[36]

10.1158/1535-7163.mct-13-1066

[37]

10.1016/s0273-2300(03)00091-6

[38]

10.1016/j.jsbmb.2008.10.002

[39]

10.1073/pnas.0308319100

[40]

Genistein protects the kidney from cisplatin-induced injury

Mi Jeong Sung, Duk Hoon Kim, Yu Jin Jung et al.

Kidney International 10.1038/ki.2008.409

[41]

Suzuki R "Genistein potentiates the antitumor effect of 5‐fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells" Anticancer Res (2014)

[42]

10.1089/ars.2007.1957

[43]

10.1124/mol.109.055178

[44]

Zhou JR "Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis" Cancer Res (1998)

Cited By

57

Cellular and Molecular Mechanisms Modulated by Genistein in Cancer

Valeria Naponelli, Annamaria Piscazzi · 2025

International Journal of Molecular...

High Concentrations of Genistein Decrease Cell Viability Depending on Oxidative Stress and Inflammation in Colon Cancer Cell Lines

Marina Alorda-Clara, Margalida Torrens-Mas · 2022

International Journal of Molecular...

Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits

Javad Sharifi-Rad, Cristina Quispe · 2021

Oxidative Medicine and Cellular Lon...

Nutraceutical Boom in Cancer: Inside the Labyrinth of Reactive Oxygen Species

Maura Calvani, Amada Pasha · 2020

International Journal of Molecular...

Metrics

57

Citations

44

References

Details

Published: Nov 19, 2015
Vol/Issue: 117(1)
Pages: 218-229
License: View

Authors

D

Daniel Gabriel Pons